We first identified that MDSCs recruited by CXCL10/TLR4 during acute phase inflammation played a critical role in tumor recurrence after liver transplantation through a series of clinical analyses, animal models, and in vitro functional experiments. The gene discussed is CXCL10; the disease is neoplasm.